Bob Shepard

Bob Shepard

| This email address is being protected from spambots. You need JavaScript enabled to view it.
Media Specialist, UAB News
(205) 934-8934 
bshep@uab.edu

A 16-year veteran of UAB, Shepard previously had a career in television news, serving as a photographer, field producer and documentary producer at stations in Lexington, Ky.; Norfolk, Va.; and Birmingham. He spends a fair amount of free time canoeing the rivers of the southern Appalachians and believes that his beloved Chicago Cubs will win the World Series this year. Finally.

Beats include: Callahan Eye Foundation Hospital; Center for Aging; Center for Palliative Care; Comprehensive Neuroscience Center; Emergency Medicine; Gene Therapy Center; Gerontology, Geriatrics and Palliative Care; Gregory F. James Cystic Fibrosis Center; Heflin Genetics Center; Nutrition Sciences; School of Health Professions; School of Medicine; Trauma, Burn and Surgical Critical Care
UAB researchers say how long your eyes take to adjust to the dark may be a risk factor for age-related macular degeneration.
UAB is using an online survey to learn more about the relationship between diet and gout.
The best breathing tube for out-of-hospital cardiac arrest is the subject of UAB-led national study.
The UAB Undiagnosed Diseases Program, designed to help find answers for rare medical conditions, now has a clinic in Children’s of Alabama.
A UAB/Children’s of Alabama/Cincinnati Children’s study finds genetic risk for fatal inflammatory disorder linked to viral infection.
The Alzheimer’s plaques that accumulate around brain cells also congregate along the walls of blood vessels, according to UAB research, and that may contribute to cognitive issues.
A diabetes drug combined with exercise may help older adults regrow muscle, and UAB’s Center for Exercise Medicine is investigating.
UAB leads a team that crafts new American College of Rheumatology guidelines for 2015 on treatment of rheumatoid arthritis.
A multisite study led by UAB has found the first biomarker for the onset of seizures in infants with tuberous sclerosis.
Southern Research and UAB launch a search for compounds that might provide new therapies for CF nonsense mutations.